Feedback (LON:FDBK) Shares Up 20.8% – Still a Buy?

Shares of Feedback plc (LON:FDBK) traded up 20.8% during trading on Tuesday . The stock traded as high as GBX 14.50 and last traded at GBX 14.49. 347,737 shares were traded during trading, an increase of 209% from the average session volume of 112,402 shares. The stock had previously closed at GBX 12.

Feedback Stock Down 1.4%

The company’s fifty day moving average price is GBX 10.87 and its two-hundred day moving average price is GBX 10.61. The company has a market cap of £6.38 million, a price-to-earnings ratio of -0.57 and a beta of 0.77.

Feedback (LON:FDBK) last announced its earnings results on Tuesday, February 17th. The company reported GBX (3.98) earnings per share for the quarter. Feedback had a negative return on equity of 39.71% and a negative net margin of 279.16%. On average, equities research analysts predict that Feedback plc will post -8 earnings per share for the current fiscal year.

Insider Activity at Feedback

In other Feedback news, insider Emma Oswick (Stuart) acquired 60,459 shares of the business’s stock in a transaction dated Tuesday, December 23rd. The shares were acquired at an average price of GBX 8 per share, with a total value of £4,836.72. Also, insider Tom Oakley bought 60,904 shares of the firm’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was acquired at an average cost of GBX 8 per share, with a total value of £4,872.32. Insiders own 7.98% of the company’s stock.

Feedback Company Profile

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.